small molecule

PARAGARD T 380A

COPPER

Loss of exclusivityJune 2027FDA regulatory exclusivity expiry

CompanyCooperSurgical →View the full company profile on CliffBio

Drug detail

Brand name	PARAGARD T 380A
Active ingredient	COPPER
Strength	309MG/COPPER
Dosage form	SYSTEM
Route	INTRAUTERINE
Modality	Small molecule
FDA approval	November 1984
Marketing status	RX

Regulatory exclusivity

Code	Expires
D-193	June 2027

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the FDA regulatory exclusivity expiry; estimates are projections, not legal advice.